Project Grant R01HL173536
- Federal Project Grant Award Summary Worcester Polytechnic Institute received a $232,500 project grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with completion targeted for August 31, 2027. The project, titled "PACE-VT: A Non-Invasive, Machine-Learning-Driven Digital Twin Approach for Precise Targeting of Ventricular Tachycardia in Cardiac Stereotactic Body...
- Federal Project Grant Award Summary Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $1,528,756 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of May 31, 2030. The award funds the development and validation of machine learning (ML) methods to automate the diagnosis of aortic stenosis (AS) from cardiac ultrasound imaging....
- Federal Grant Award Summary Worcester Polytechnic Institute received a $555,371 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026 through May 31, 2029. The award funds the development and validation of two novel in vitro bioengineered models of intramural uterine fibroids designed to advance understanding of fibroid pathophysiology and...
- Federal Project Grant Award Summary Massachusetts Institute of Technology received a $397,034 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion scheduled for July 31, 2027. The grant supports development of a transcatheter manufacturing toolkit for creating patient-specific, minimally-invasive left atrial appendage occlusion (LAAO) devices to prevent stroke in...
- Federal Grant Award Summary Brigham and Women's Hospital received an $800,962 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with a completion date of June 30, 2030. This award supports research investigating the mechanisms of endothelial inflammation, C-terminal Src kinase (CSK) dysregulation, and fibrosis in early pulmonary arterial hypertension (PAH). The primary research...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $171,858 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with an ultimate completion date of July 31, 2030. The award funds a research initiative titled "Computed Tomography for Early Detection and Phenotyping of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease...
- Federal Project Grant Award Summary The University of Colorado-Denver received a $468,000 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with an award date of August 1, 2025, and completion scheduled for July 31, 2027. This project supports secondary analysis of noninvasive imaging biomarkers to predict single ventricle failure, a critical congenital heart defect affecting approximately 2 in 10,000 live...
- Federal Grant Award Summary Brigham and Women's Hospital received an $855,585 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 20, 2025, with completion scheduled for July 31, 2028. This project focuses on developing and adapting antihypertensive self-titration interventions for implementation in U.S. primary care settings. The research addresses the critical public health challenge that...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Maryland, Baltimore a $777,016 Project Grant on August 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research through May 31, 2029. This project aims to deliver functional characterization and validation of genetic variants associated with hypoplastic heart syndrome (HHS), a severe congenital heart disease affecting approximately 1 in 5,000...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $865,286 to Boston Children's Hospital (The Children's Hospital Corporation) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of June 30, 2029. This research initiative will produce a high-resolution spatiotemporal lineage map of cardiac development by integrating advanced lineage tracing, spatial, and single-cell...
Worcester Polytechnic Institute (WPI) received a $759,243 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective June 1, 2026, with completion scheduled for February 28, 2030. The grant funds the development of novel personalized computational flow models to assess high-fidelity hemodynamics of the fetal aorta and improve prenatal diagnosis of coarctation of the aorta (COA), a congenital heart defect affecting 6-8% of live births with congenital heart disease. The research addresses limitations in contemporary prenatal imaging techniques that result in frequent false positive and false negative diagnoses. The deliverables include: (1) development of a personalized computational flow model of the fetal aorta validated against in vivo measurements using clinically routine imaging; (2) creation of an in vitro flow model for validation of novel hemodynamic flow metrics; and (3) evaluation of novel flow metrics—including wall shear stress measurements—to improve COA diagnosis in fetuses. The project leverages an existing cohort of 500 fetal cases (250 normal aortas and 250 with COA) from the Fetal Heart Society to develop and test these modeling approaches, offering a cost-effective alternative to enhance diagnostic accuracy for this critical perinatal condition.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $759.2k | 6/3/26 |